000			01949 a2200493 4500
005			20250515223051.0
264		0	_c20100820
008			201008s 0 0 eng d
022			_a1538-8514
024	7		_a10.1158/1535-7163.MCT-09-1169 _2doi
040			_aNLM _beng _cNLM
100	1		_aNing, Yanxia
245	0	0	_aIFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis. _h[electronic resource]
260			_bMolecular cancer therapeutics _cMay 2010
300			_a1274-85 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCarcinoma _xdrug therapy
650	0	4	_aCaspases _xmetabolism
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aDrug Synergism
650	0	4	_aEstradiol _xanalogs & derivatives
650	0	4	_aFemale
650	0	4	_aFulvestrant
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aHumans
650	0	4	_aInterferon Regulatory Factor-1 _xgenetics
650	0	4	_aInterferon-gamma _xpharmacology
650	0	4	_aNF-kappa B _xgenetics
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xgenetics
650	0	4	_aSTAT1 Transcription Factor _xgenetics
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTumor Cells, Cultured
700	1		_aRiggins, Rebecca B
700	1		_aMulla, Jennifer E
700	1		_aChung, Haniee
700	1		_aZwart, Alan
700	1		_aClarke, Robert
773	0		_tMolecular cancer therapeutics _gvol. 9 _gno. 5 _gp. 1274-85
856	4	0	_uhttps://doi.org/10.1158/1535-7163.MCT-09-1169 _zAvailable from publisher's website
999			_c19812677 _d19812677